查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
心臟監測設備和心律管理設備市場：按類型、程序、應用、最終用戶、地區 - 預測到 2029 年
市場調查報告書
商品編碼
1474716

心臟監測設備和心律管理設備市場：按類型、程序、應用、最終用戶、地區 - 預測到 2029 年

Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 298 Pages | 訂單完成後即時交付

價格
簡介目錄

全球心臟監測和心律管理設備市場規模預計將從 2024 年的 213 億美元增加到 2029 年的 264 億美元，預測期內複合年成長率為 4.3%。

該市場的推動因素包括公眾意識提升宣傳活動的加強和旨在早期發現心血管疾病的篩檢計劃，導致對心臟監測設備的需求不斷成長，特別是在高風險人群中。另一方面，遠端監控和遠端醫療技術的採用引發了資料安全和病患隱私問題，可能會阻礙病患接受和採用這些設備。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（十億美元）
部分 按類型、技術、應用程式、最終用戶、地區
目標區域 亞太地區、北美、拉丁美洲、中東/非洲和海灣合作理事會國家

心律管理設備市場中的心臟去顫器依類型分為植入式心臟整流去顫器和體外心臟去顫器。 2023年，植入式心臟去顫器佔據主要市場佔有率。這是因為植入式心臟去顫器透過持續監測心律並在需要時提供適當的治療來提供持續的保護，防止心臟麻痹。雖然體外心臟去顫器通常用於緊急情況下的緊急干預，但這種持續監測和干涉可以全天候保護面臨危及生命的心律不整風險的患者。同樣，植入式心臟去顫器透過手術或微創手術植入因心室心律不整或心肌病等潛在疾病而導致心因性猝死的高風險患者。它們適合長期使用，適合需要持續心律不整管理的患者。另一方面，醫院使用的體外心臟去顫器，例如自動體外心臟去顫器（AED）和手動心臟去顫器，主要用於心臟麻痹時的緊急復甦。

心臟監測設備的心臟事件記錄器市場依技術分為患者啟動型和自動檢測型。患者發起的心臟事件記錄器需要患者的積極參與，這會在出現心悸或頭暈等症狀時觸發事件記錄。與可能錯過瞬態或亞臨床事件的自動檢測監測器相比，這種患者的參與提高了對監測通訊協定的依從性，並導致更可靠的資料收集。此外，患者啟動的心臟事件記錄器比自動偵測監測器更具成本效益，特別是對於症狀不常見或間歇性的患者。

該報告研究了全球心臟監測和節律管理設備市場，包括按類型、程序、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 波特五力分析
  • 生態系/市場地圖
  • 價值鏈分析
  • 供應鏈分析
  • 監管狀況
  • 價格分析
  • 貿易分析
  • 技術分析
  • 專利分析
  • 2024-2025年重大會議和活動
  • 影響客戶業務的趨勢/干擾
  • 主要相關人員和採購標準

第6章心臟監測設備市場（按類型）

  • 介紹
  • 心電圖儀
  • MCT裝置
  • 通訊設備

第7章節律管理設備市場（依類型）

  • 介紹
  • 心臟去顫器
  • 心律調節器

第8章心臟監測設備和節律管理設備市場，依程序

  • 介紹
  • 侵入性手術
  • 非侵入性手術

第9章心臟監測設備和心律管理設備市場（按應用）

  • 介紹
  • 心律不整
  • 心肌梗塞
  • 心臟衰竭
  • 其他

第 10 章心臟監測設備和心律管理設備市場（依最終用戶）

  • 介紹
  • 醫院
  • 診所、心臟中心、門診手術中心
  • 其他

第11章心臟監測設備和心律管理設備市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第12章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 市場佔有率分析
  • 收益佔有率分析
  • 企業評價矩陣：主要參與企業
  • 公司評估矩陣：Start-Ups/中小企業
  • 心臟監測和節律管理設備供應商評估和財務指標
  • 競爭場景
  • 品牌/產品比較

第13章 公司簡介

  • 主要參與企業
    • ABBOTT LABORATORIES
    • MEDTRONIC
    • BOSTON SCIENTIFIC CORPORATION
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • ASAHI KASEI CORPORATION
    • MICROPORT SCIENTIFIC CORPORATION
    • BAXTER
    • NIHON KOHDEN CORPORATION
    • BIOTRONIK
    • SCHILLER
    • ACS DIAGNOSTICS
    • BPL MEDICAL TECHNOLOGIES
    • BTL
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 其他公司
    • OSYPKA AG
    • ALIVECOR, INC.
    • AMIITALIA
    • BEXEN CARDIO
    • NARANG MEDICAL LIMITED
    • PRIMEDIC
    • PROGETTI
    • INNOMED MEDICAL INC.
    • LUMED SRL
    • NASIFF ASSOCIATES INC.

第14章附錄

簡介目錄
Product Code: MD 1038

The global cardiac monitoring & cardiac rhythm management devices market is expected to reach USD 26.4 Billion by 2029 from USD 21.3 Billion in 2024, at a CAGR of 4.3% during the forecast period. Market is driven by factors such as rising public awareness campaigns and screening programs aimed at detecting cardiovascular diseases early contribute to the growing demand for cardiac monitoring devices, especially in high-risk populations. On the other hand, The adoption of remote monitoring and telemedicine technologies raises concerns about data security and patient privacy, which may hinder patient acceptance and adoption of these devices.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsEnteral feeding devices - Type, Age Group, Application, End user and Region
Regions coveredAsia Pacific, North America, Europe, Latin America, and the Middle East and Africa and GCC countries

"The Implantable Cardioverter Defibrillators accounted for the largest market share in the Cardiac Rhythm Management Device market, during the forecast period"

Based on the type, Defibrillators in Cardiac Rhythm Management Devices Market is classified into Implantable Cardioverter Defibrillators, External Defibrillators. In 2023, Implantable Cardioverter Defibrillators accounted for a sizable market share because Implantable defibrillators provide continuous protection against sudden cardiac arrest by constantly monitoring the heart's rhythm and delivering appropriate therapy when needed. This continuous monitoring and intervention offer round-the-clock protection for patients at risk of life-threatening arrhythmias, whereas external defibrillators are typically used for acute interventions in emergency situations. Likewise, Implantable defibrillators are implanted surgically or via minimally invasive procedures in patients at high risk of sudden cardiac death due to underlying cardiac conditions such as ventricular arrhythmias or cardiomyopathy. They are intended for long-term use and are suitable for patients who require ongoing arrhythmia management. In contrast, external defibrillators, such as automated external defibrillators (AEDs) or manual defibrillators used in hospitals, are primarily used for emergency resuscitation in cases of cardiac arrest.

"Patient Activated technology segment accounted for the largest market share"

Based on technology, the Event monitor's in cardiac monitoring devices market is segmented into -Patient Activated, Auto Detected. The Patient Activated technology segment accounted for the largest market share in 2023., due to its variety of applications such as, Patient-activated event monitors require the active participation of the patient, who triggers the recording of an event when they experience symptoms such as palpitations or dizziness. This level of patient engagement can lead to higher compliance with monitoring protocols and more reliable data collection compared to auto-detected monitors, which may miss transient or asymptomatic events. Moreover, Patient-activated event monitors may be more cost-effective than auto-detected monitors, particularly for patients with infrequent or intermittent symptoms.

"North American region accounted for the Second highest CAGR"

The global cardiac monitoring & cardiac rhythm management devices market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the North American region is likely to retain a considerable market share in 2023 and the future. The North American market is being propelled by an rising cases of heart diseases, rising in healthcare expenditure, rising in awareness about early disease diagnosis.

"Europe is estimated to register the third highest CAGR during the forecast period."

In this report, the cardiac monitoring & cardiac rhythm management devices market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the third highest growth rate during the forecast period. The growth in this market is due to Europe has a strong tradition of research and academic excellence, the rising incidence of aging population followed by cardiac diseases, government funding for research and healthcare in many European countries supports the development and adoption of advanced diagnostic technologies such as cardiac screening.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
  • By Designation: C-level - 30%, D-level - 34%, and Others - 36%
  • By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World - 12%

Lits of Companies Profiled in the Report:

  • Abbott Laboratories (US)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • GE HealthCare (US)
  • Koninklijke Philips N.V. (Netherlands)
  • Asahi Kasei Corporation. (Japan)
  • MicroPort Scientific Corporatio (China)
  • Baxter.(US)
  • NIHON KOHDEN CORPORATION.(Japan)
  • BIOTRONIK (Germany)
  • SCHILLER (Switzerland)
  • ACS Diagnostics.(US)
  • BPL Medical Technologies (India)
  • BTL (US)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.(China)
  • OSYPKA AG (Germany)
  • AliveCor, Inc.(US)
  • Amiitalia (Italy)
  • Bexen Cardio (Spain)
  • Narang Medical Limited (India)
  • Primedic (Germany)
  • Progetti (Italy)
  • INNOMED MEDICAL INC.(Hungary)
  • LUMED srl (Italy)
  • Nasiff Associates Inc. (US)

Research Coverage:

This report studies the cardiac monitoring & cardiac rhythm management devices market based on Type, Application, Procedure, End User, and Region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cardiac monitoring & cardiac rhythm management devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Drivers: Comprehensive information about driving factors of the markets. The report analyses the markets drivers across key geographic regions.

Market Penetration: Comprehensive information on cardiac monitoring & cardiac rhythm management devices Market products offered by the top 25 players in the market. The report analyses the cardiac monitoring & cardiac rhythm management devices market by Product & Service, Type, Medical Condition, Technology, End User, and Region.

Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various securement devices across key geographic regions.

Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cardiac monitoring & cardiac rhythm management devices market

Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cardiac monitoring & cardiac rhythm management devices market

Market Position: It will upkeep stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
    • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
      • 2.2.2.3 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.3.2 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.3 TOP-DOWN APPROACH
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS
    • FIGURE 9 ASSUMPTIONS FOR RESEARCH
  • 2.6 LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 15 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW
    • FIGURE 16 GROWING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET
  • 4.2 ECG DEVICES MARKET, BY TYPE, 2024-2029
    • FIGURE 17 RESTING ECG DEVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.3 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER (2024)
    • FIGURE 18 US AND INVASIVE PROCEDURES TO DOMINATE NORTH AMERICAN MARKET IN 2024
  • 4.4 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIAN COUNTRIES TO REGISTER HIGHER GROWTH FROM 2024 TO 2029

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population and subsequent increase in CVD prevalence
    • FIGURE 21 HEART AND CIRCULATORY DISEASE PREVALENCE: GLOBAL STATISTICS (2021)
      • 5.2.1.2 Availability of reimbursement for CM & CRM devices
    • TABLE 2 CPT CODES FOR CM & CRM DEVICES, 2020
      • 5.2.1.3 Rising awareness and prevention initiatives
      • 5.2.1.4 Increasing investments, funds, and grants for research
      • 5.2.1.5 Growing preference for wearable cardiac devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High device costs
      • 5.2.2.2 Adverse effects and associated complications
    • TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Measures to reduce infections caused by CIEDs
      • 5.2.3.2 Untapped emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Risk of associated cybersecurity vulnerabilities
      • 5.2.4.2 Frequent product recalls
    • TABLE 4 KEY PRODUCT RECALLS
      • 5.2.4.3 Stringent regulatory requirements delaying the approval of cardiac devices
      • 5.2.4.4 Dearth of skilled professionals
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 ECOSYSTEM/MARKET MAP
    • FIGURE 22 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM
    • TABLE 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: ROLE IN ECOSYSTEM
    • FIGURE 23 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET: KEY PLAYERS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 25 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.7.2 NORTH AMERICA
      • 5.7.2.1 US
      • 5.7.2.2 Canada
    • 5.7.3 EUROPE
    • 5.7.4 ASIA PACIFIC
      • 5.7.4.1 China
      • 5.7.4.2 Japan
      • 5.7.4.3 India
    • 5.7.5 LATIN AMERICA
      • 5.7.5.1 Brazil
      • 5.7.5.2 Mexico
    • 5.7.6 MIDDLE EAST
    • 5.7.7 AFRICA
  • 5.8 PRICING ANALYSIS
    • 5.8.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
    • TABLE 12 AVERAGE SELLING PRICE OF HOLTER ECG MONITORS
    • TABLE 13 AVERAGE SELLING PRICE OF DEFIBRILLATORS
  • 5.9 TRADE ANALYSIS
    • TABLE 14 IMPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 15 EXPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 HOLTER MONITOR
    • 5.10.2 DEFIBRILLATORS
  • 5.11 PATENT ANALYSIS
    • FIGURE 26 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TOP 10 COMPANIES (APPLICATIONS/OWNERS)
  • 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
    • TABLE 16 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: LIST OF CONFERENCES AND EVENTS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 27 REVENUE SHIFT IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS
    • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%)
    • 5.14.2 BUYING CRITERIA
    • FIGURE 29 KEY BUYING CRITERIA FOR TOP TWO END USERS
    • TABLE 18 KEY BUYING CRITERIA FOR TOP TWO END USERS

6 CARDIAC MONITORING DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 6.2 ECG DEVICES
    • TABLE 20 ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 21 ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Low cost, ease of use, and simplicity to drive adoption
    • TABLE 22 RESTING ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 High device cost to affect adoption rate
    • TABLE 23 STRESS ECG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Short duration of monitoring to restrain adoption
    • TABLE 24 HOLTER MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.4 EVENT MONITORS
    • TABLE 25 EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 6.2.4.1 Event monitors market, by type
    • TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
        • 6.2.4.1.1 Loop memory monitors
          • 6.2.4.1.1.1 Large storage capacity to support use in long-term monitoring
    • TABLE 27 LOOP MEMORY MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 6.2.4.1.2 Patch recorders
          • 6.2.4.1.2.1 Patch recorders to play valuable role in diagnosing and managing cardiac conditions
    • TABLE 28 PATCH RECORDER EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 6.2.4.1.3 Symptom event monitors
          • 6.2.4.1.3.1 Ease of use and on-demand recording to drive adoption
    • TABLE 29 SYMPTOM EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 6.2.4.1.4 Implanted loop recorders
          • 6.2.4.1.4.1 High cost and limited applications to hinder demand growth
    • TABLE 30 IMPLANTED LOOP RECORDERS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 6.2.4.2 Event monitors market, by technology
    • TABLE 31 EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
        • 6.2.4.2.1 Patient-activated event monitors
          • 6.2.4.2.1.1 Need for manual activation to slow market growth
    • TABLE 32 PATIENT-ACTIVATED EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 6.2.4.2.2 Auto-detect event monitors
          • 6.2.4.2.2.1 Auto-detect monitors to show higher CAGR in event monitors segment
    • TABLE 33 AUTO-DETECT EVENT MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.5 SMART ECG MONITORS
      • 6.2.5.1 Lack of data security to hinder market growth
    • TABLE 34 INDICATIVE LIST OF SMART ECG MONITORS
    • TABLE 35 SMART ECG MONITORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.3 MCT DEVICES
    • 6.3.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS TO PROPEL MARKET GROWTH
    • TABLE 36 MCT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.4 COM DEVICES
    • 6.4.1 RISING NUMBER OF CARDIAC SURGERIES TO DRIVE DEMAND FOR COM DEVICES
    • TABLE 37 TYPES OF COM DEVICES
    • TABLE 38 COM DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)

7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 39 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 40 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2023-2029 (UNITS)
  • 7.2 DEFIBRILLATORS
    • TABLE 41 DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 42 DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.2.1.1 Transvenous ICDs
    • TABLE 45 TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 46 TRANSVENOUS ICDS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 7.2.1.1.1 Biventricular ICDS/CRT-Ds
          • 7.2.1.1.1.1 Greater preference in heart failure patients to drive market
    • TABLE 47 BIVENTRICULAR ICDS/CRT-DS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 7.2.1.1.2 Dual-chamber ICDs
          • 7.2.1.1.2.1 Higher diagnostic accuracy to support usage
    • TABLE 48 DUAL-CHAMBER ICDS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 7.2.1.1.3 Single-chamber ICDs
          • 7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs to support market growth
    • TABLE 49 SINGLE-CHAMBER ICDS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.2.1.2 Subcutaneous ICDs
        • 7.2.1.2.1 Safety and efficacy of S-ICDs to boost adoption
    • TABLE 50 SUBCUTANEOUS ICDS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 7.2.2 EXTERNAL DEFIBRILLATORS
    • TABLE 51 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 52 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.2.2.1 Automated external defibrillators
    • TABLE 53 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED US FDA PRE-MARKET APPROVAL (2018-2022)
    • TABLE 54 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 55 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 7.2.2.1.1 Semi-automated external defibrillators
          • 7.2.2.1.1.1 Semi-automated external defibrillators to hold largest market share
    • TABLE 56 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
        • 7.2.2.1.2 Fully automated external defibrillators
          • 7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy to drive market
    • TABLE 57 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.2.2.2 Manual external defibrillators
        • 7.2.2.2.1 North America to dominate manual defibrillators market
    • TABLE 58 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.2.2.3 Wearable cardioverter defibrillators
        • 7.2.2.3.1 Ease of use and noninvasive nature to support market growth
    • TABLE 59 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 7.3 PACEMAKERS
    • TABLE 60 PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY
    • TABLE 61 PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
      • 7.3.1.1 Implantable pacemakers
        • 7.3.1.1.1 Introduction of leadless and MRI-safe devices to boost adoption
    • TABLE 62 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.3.1.2 External pacemakers
        • 7.3.1.2.1 Increasing number of open-heart surgeries to drive demand
    • TABLE 63 EXTERNAL PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 7.3.2 PACEMAKERS MARKET, BY TYPE
    • TABLE 64 PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
      • 7.3.2.1 Biventricular/CRT-Ps
        • 7.3.2.1.1 High cost and unfavorable reimbursement to hinder growth
    • TABLE 65 BIVENTRICULAR/CRT-PS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.3.2.2 Dual-chamber pacemakers
        • 7.3.2.2.1 Dual-chamber pacemakers to witness high demand due to widespread usage
    • TABLE 66 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION)
      • 7.3.2.3 Single-chamber pacemakers
        • 7.3.2.3.1 Introduction of leadless pacemakers to stimulate demand
    • TABLE 67 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2022-2029 (USD MILLION)

8 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE

  • 8.1 INTRODUCTION
    • TABLE 68 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • 8.2 INVASIVE PROCEDURES
    • 8.2.1 GROWING NUMBER OF CARDIAC PROCEDURES TO DRIVE MARKET GROWTH
    • TABLE 69 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR INVASIVE PROCEDURES, BY REGION, 2022-2029 (USD MILLION)
  • 8.3 NON-INVASIVE PROCEDURES
    • 8.3.1 GROWING PREVALENCE OF LIFESTYLE AND GENETIC DISEASES TO PROPEL ADOPTION
    • TABLE 70 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR NON-INVASIVE PROCEDURES, BY REGION, 2022-2029 (USD MILLION)

9 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 71 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.2 ARRHYTHMIAS
    • 9.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET
    • TABLE 72 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY REGION, 2022-2029 (USD MILLION)
  • 9.3 MYOCARDIAL INFARCTION
    • 9.3.1 RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
    • TABLE 73 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION, 2022-2029 (USD MILLION)
  • 9.4 HEART FAILURE
    • 9.4.1 GROWING AGING POPULATION TO DRIVE PREVALENCE OF HEART FAILURE
    • TABLE 74 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HEART FAILURE, BY REGION, 2022-2029 (USD MILLION)
  • 9.5 OTHER APPLICATIONS
    • TABLE 75 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)

10 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 76 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2 HOSPITALS
    • 10.2.1 RISING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET
    • TABLE 77 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • 10.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS
    • 10.3.1 GROWING FOCUS ON AMBULATORY CARE IN US TO PROPEL DEVICE ADOPTION
    • TABLE 78 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • 10.4 OTHER END USERS
    • TABLE 79 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)

11 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 80 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 81 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 82 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 30 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
    • TABLE 83 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 85 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 87 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 88 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 89 NORTH AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 90 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 91 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 92 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 93 NORTH AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 94 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 95 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 96 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 97 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 98 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 99 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 100 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 US to hold largest market share in North America
    • TABLE 101 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 102 US: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 103 US: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 104 US: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 105 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 106 US: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 107 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 108 US: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 109 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 110 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 111 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 112 US: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 113 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 114 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 115 US: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Growing funding for research to drive market
    • TABLE 116 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 117 CANADA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 118 CANADA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 119 CANADA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 120 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 121 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 122 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 123 CANADA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 124 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 125 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 126 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 127 CANADA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 128 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 129 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 130 CANADA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • TABLE 131 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 132 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 133 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 134 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 135 EUROPE: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 136 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 137 EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 138 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 139 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 140 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 141 EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 142 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 143 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 144 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 145 EUROPE: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 146 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 147 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 148 EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Increasing healthcare expenditure to drive market growth
    • TABLE 149 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 150 GERMANY: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 151 GERMANY: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 152 GERMANY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 153 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 154 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 155 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 156 GERMANY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 157 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 159 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 160 GERMANY: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 161 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 162 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 163 GERMANY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Rising prevalence of heart failure to boost adoption of CRT devices
    • TABLE 164 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 165 FRANCE: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 166 FRANCE: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 167 FRANCE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 168 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 169 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 170 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 171 FRANCE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 172 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 173 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 174 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 175 FRANCE: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 176 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 177 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 178 FRANCE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.4 UK
      • 11.3.4.1 Rising demand for home-based cardiac monitoring devices to support market growth
    • TABLE 179 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 180 UK: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 181 UK: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 182 UK: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 183 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 184 UK: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 185 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 186 UK: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 187 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 188 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 189 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 190 UK: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 191 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 192 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 193 UK: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Increasing incidence of atrial fibrillation to drive market
    • TABLE 194 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSANDS)
    • TABLE 195 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 196 ITALY: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 197 ITALY: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 198 ITALY: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 199 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 200 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 201 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 202 ITALY: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 203 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 204 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 205 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 206 ITALY: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 207 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 208 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 209 ITALY: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Rising awareness and growing device adoption to support market growth
    • TABLE 210 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 211 SPAIN: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 212 SPAIN: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 213 SPAIN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 214 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 215 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 216 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 217 SPAIN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 218 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 219 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 220 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 221 SPAIN: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 222 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 223 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 224 SPAIN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 225 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2029 VS. 2050
    • TABLE 226 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 227 REST OF EUROPE: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 228 REST OF EUROPE: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 229 REST OF EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 230 REST OF EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 231 REST OF EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 232 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 233 REST OF EUROPE: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 234 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 235 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 236 REST OF EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 237 REST OF EUROPE: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 238 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 239 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 240 REST OF EUROPE: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 31 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
    • TABLE 241 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 243 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 244 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 245 ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 246 ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 247 ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 248 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 249 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 250 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 251 ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 252 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 253 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 254 ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 255 ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 256 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 257 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 258 ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 High healthcare expenditure and favorable reimbursement & insurance policies to support market growth
    • TABLE 259 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 260 JAPAN: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 261 JAPAN: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 262 JAPAN: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 263 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 264 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 265 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 266 JAPAN: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 267 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 268 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 269 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 270 JAPAN: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 271 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 272 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 273 JAPAN: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Rising prevalence of CVDs and government support for infrastructural improvement to drive market
    • TABLE 274 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 275 CHINA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 276 CHINA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 CHINA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 278 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 279 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 280 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 281 CHINA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 282 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 283 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 284 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 285 CHINA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 286 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 287 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 288 CHINA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Increasing incidence of CVD to propel market growth
    • TABLE 289 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 290 INDIA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 291 INDIA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 292 INDIA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 293 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 294 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 295 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 296 INDIA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 297 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 298 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 299 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 300 INDIA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 301 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 302 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 303 INDIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.5 REST OF ASIA PACIFIC
    • TABLE 304 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 305 REST OF ASIA PACIFIC: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 306 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 307 REST OF ASIA PACIFIC: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 308 REST OF ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 309 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 310 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 311 REST OF ASIA PACIFIC: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 312 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 313 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 314 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 315 REST OF ASIA PACIFIC: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 316 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 317 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 318 REST OF ASIA PACIFIC: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • 11.5.1 REST OF THE WORLD: RECESSION IMPACT
    • TABLE 319 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 320 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 321 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 322 REST OF THE WORLD: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 323 REST OF THE WORLD: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 324 REST OF THE WORLD: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 325 REST OF THE WORLD: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 326 REST OF THE WORLD: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 327 REST OF THE WORLD: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 328 REST OF THE WORLD: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 329 REST OF THE WORLD: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 330 REST OF THE WORLD: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 331 REST OF THE WORLD: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 332 REST OF THE WORLD: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 333 REST OF THE WORLD: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 334 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 335 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 336 REST OF THE WORLD: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.5.2 LATIN AMERICA
      • 11.5.2.1 Rising patient population and growing disease incidence to support market growth
    • TABLE 337 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 338 LATIN AMERICA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 339 LATIN AMERICA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 340 LATIN AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 341 LATIN AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 342 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 343 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 344 LATIN AMERICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 345 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 346 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 347 LATIN AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 348 LATIN AMERICA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 349 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 350 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 351 LATIN AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.5.3 MIDDLE EAST & AFRICA
      • 11.5.3.1 Prominence of local players and healthcare infrastructural improvements to support growth
    • TABLE 352 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 353 MIDDLE EAST & AFRICA: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 354 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 355 MIDDLE EAST & AFRICA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 356 MIDDLE EAST & AFRICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 357 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 358 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 359 MIDDLE EAST & AFRICA: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 360 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 361 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 362 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 363 MIDDLE EAST & AFRICA: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 364 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 365 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 366 MIDDLE EAST & AFRICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.5.4 GCC COUNTRIES
      • 11.5.4.1 Increasing awareness and government initiatives to favor market growth
    • TABLE 367 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 368 GCC COUNTRIES: ECG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 369 GCC COUNTRIES: EVENT MONITORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 370 GCC COUNTRIES: EVENT MONITORS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 371 GCC COUNTRIES: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 372 GCC COUNTRIES: DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 373 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 374 GCC COUNTRIES: TRANSVENOUS ICDS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 375 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 376 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 377 GCC COUNTRIES: PACEMAKERS MARKET, BY IMPLANTABILITY, 2022-2029 (USD MILLION)
    • TABLE 378 GCC COUNTRIES: PACEMAKERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 379 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 380 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
    • TABLE 381 GCC COUNTRIES: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 382 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING DEVICES & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • 12.3 MARKET SHARE ANALYSIS
    • TABLE 383 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION
  • 12.4 REVENUE SHARE ANALYSIS
    • FIGURE 32 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 33 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 12.5.5 COMPANY FOOTPRINT
    • FIGURE 34 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY FOOTPRINT
    • TABLE 384 COMPANY FOOTPRINT
    • TABLE 385 PRODUCT FOOTPRINT
    • TABLE 386 REGIONAL FOOTPRINT
  • 12.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 35 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (START-UP/SME PLAYERS), 2023
    • 12.6.5 COMPETITIVE BENCHMARKING
    • TABLE 387 DETAILED LIST OF KEY START-UPS/SMES IN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
  • 12.7 VALUATION AND FINANCIAL METRICS OF CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICE VENDORS
    • FIGURE 36 EV/EBITDA OF KEY VENDORS
    • FIGURE 37 EV/REV OF KEY VENDORS
    • FIGURE 38 BETA (5 YEARS) OF KEY VENDORS
    • FIGURE 39 1-YEAR PRICE TOTAL RETURN OF KEY VENDORS
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 388 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2024
    • 12.8.2 DEALS
    • TABLE 389 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2021-APRIL 2024
  • 12.9 BRAND/PRODUCT COMPARISON

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 ABBOTT LABORATORIES
    • TABLE 390 ABBOTT LABORATORIES: COMPANY OVERVIEW
    • FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT
    • TABLE 391 ABBOTT LABORATORIES: PRODUCTS OFFERED
    • TABLE 392 ABBOTT LABORATORIES: PRODUCT LAUNCHES (JANUARY 2021-APRIL 2024)
    • 13.1.2 MEDTRONIC
    • TABLE 393 MEDTRONIC: COMPANY OVERVIEW
    • FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT
    • TABLE 394 MEDTRONIC: PRODUCTS OFFERED
    • 13.1.3 BOSTON SCIENTIFIC CORPORATION
    • TABLE 395 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • TABLE 396 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
    • TABLE 397 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS (JANUARY 2021-APRIL 2024)
    • 13.1.4 GE HEALTHCARE
    • TABLE 398 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT
    • TABLE 399 GE HEALTHCARE: PRODUCTS OFFERED
    • 13.1.5 KONINKLIJKE PHILIPS N.V.
    • TABLE 400 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
    • TABLE 401 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
    • TABLE 402 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES (JANUARY 2021-APRIL 2024)
    • 13.1.6 ASAHI KASEI CORPORATION
    • TABLE 403 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
    • FIGURE 45 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
    • TABLE 404 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
    • 13.1.7 MICROPORT SCIENTIFIC CORPORATION
    • TABLE 405 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • TABLE 406 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
    • 13.1.8 BAXTER
    • TABLE 407 BAXTER: COMPANY OVERVIEW
    • FIGURE 47 BAXTER: COMPANY SNAPSHOT
    • TABLE 408 BAXTER: PRODUCTS OFFERED
    • TABLE 409 BAXTER: DEALS (JANUARY 2021-APRIL 2024)
    • 13.1.9 NIHON KOHDEN CORPORATION
    • TABLE 410 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
    • FIGURE 48 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
    • TABLE 411 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
    • TABLE 412 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES (JANUARY 2021-APRIL 2024)
    • 13.1.10 BIOTRONIK
    • TABLE 413 BIOTRONIK: COMPANY OVERVIEW
    • TABLE 414 BIOTRONIK: PRODUCTS OFFERED
    • 13.1.11 SCHILLER
    • TABLE 415 SCHILLER: COMPANY OVERVIEW
    • TABLE 416 SCHILLER: PRODUCTS OFFERED
    • 13.1.12 ACS DIAGNOSTICS
    • TABLE 417 ACS DIAGNOSTICS: COMPANY OVERVIEW
    • TABLE 418 ACS DIAGNOSTICS: PRODUCTS OFFERED
    • 13.1.13 BPL MEDICAL TECHNOLOGIES
    • TABLE 419 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
    • TABLE 420 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
    • 13.1.14 BTL
    • TABLE 421 BTL: COMPANY OVERVIEW
    • TABLE 422 BTL: PRODUCTS OFFERED
    • 13.1.15 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • TABLE 423 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
    • TABLE 424 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • 13.2 OTHER PLAYERS
    • 13.2.1 OSYPKA AG
    • 13.2.2 ALIVECOR, INC.
    • 13.2.3 AMIITALIA
    • 13.2.4 BEXEN CARDIO
    • 13.2.5 NARANG MEDICAL LIMITED
    • 13.2.6 PRIMEDIC
    • 13.2.7 PROGETTI
    • 13.2.8 INNOMED MEDICAL INC.
    • 13.2.9 LUMED SRL
    • 13.2.10 NASIFF ASSOCIATES INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS